MG - MYASTHENIA GRAVIS

Clinical trials for MG - MYASTHENIA GRAVIS explained in plain language.

Never miss a new study

Get alerted when new MG - MYASTHENIA GRAVIS trials appear

Sign up with your email to follow new studies for MG - MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New dosing strategy tested for muscle-weakening disease

Disease control Completed

This study tested whether giving a medication called efgartigimod continuously or in cycles works better for people with generalized myasthenia gravis, a condition that causes muscle weakness. The trial involved 69 adults who received the medication for up to 138 weeks. Researche…

Matched conditions: MG - MYASTHENIA GRAVIS

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

MG - MYASTHENIA GRAVIS

Get alerted when new MG - MYASTHENIA GRAVIS trials appear

New dosing strategy tested for muscle-weakening disease